Bahrain Signs its Participation Contract for Expo 2030 Riyadh
3.9.2026 17:45:00 CEST | Business Wire | Press release
The Kingdom of Bahrain has signed its Participation Contract for Expo 2030 Riyadh, marking a new phase in preparations for its participation in the World Expo.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260903144412/en/

His Excellency Sheikh Khalifa bin Ahmed Al Khalifa, President of the Bahrain Authority for Culture and Antiquities, and Talal Al-Marri, Chief Executive Officer of Expo 2030 Riyadh, at the ceremony.
The agreement provides the formal framework for Bahrain’s participation in Expo 2030 Riyadh, enabling preparations to advance across the key organizational and operational aspects of its presence throughout the six-month event, including the development of its pavilion, programmes and visitor experiences.
The Participation Contract was signed in Bahrain by Talal Al-Marri, Chief Executive Officer of Expo 2030 Riyadh, on behalf of Expo 2030 Riyadh, and His Excellency Sheikh Khalifa bin Ahmed Al Khalifa, President of the Bahrain Authority for Culture and Antiquities, on behalf of the Kingdom of Bahrain.
His Excellency Sheikh Khalifa bin Ahmed Al Khalifa President of the Bahrain Authority for Culture and Antiquities, commented: “Bahrain’s participation in Expo 2030 Riyadh reflects the deep-rooted fraternal and historic ties between the Kingdom of Bahrain and the Kingdom of Saudi Arabia, as well as the growing cooperation between the two countries across a wide range of fields.”
He added, “The signing of the Participation Contract marks an important milestone in Bahrain’s preparations for Expo 2030 Riyadh and reflects the Kingdom’s commitment to playing an active role in this global event. Bahrain looks forward to presenting a participation that showcases its identity, achievements and future aspirations, while further strengthening its presence on the international stage. We aim to deliver a comprehensive national presence that reflects the significance of the event and the global platform it provides for cultural and knowledge exchange and building partnerships.”
Talal Al-Marri, Chief Executive Officer of Expo 2030 Riyadh, said: “The signing of Bahrain’s Participation Contract marks an important step in the preparations for Expo 2030 Riyadh and reflects the growing momentum as participating countries move from confirming their participation to delivering what they will bring to Riyadh in 2030. As Participation Contracts are signed, Expo 2030 Riyadh is increasingly taking shape through the pavilions, programmes and experiences that participating countries will bring to visitors. We look forward to working closely with the Bahrain team in the next phase and to seeing a distinctive participation come to life – one that reflects Bahrain’s vision, culture and ambitions, while enriching the overall Expo 2030 Riyadh experience.”
The signing of Bahrain’s Participation Contract marks an important milestone in its journey towards Expo 2030 Riyadh, moving its participation from the confirmation and preparation stage into planning and implementation. Bahrain is also expected to develop a sustainable pavilion designed to remain beyond the six-month event and become part of the Global Village, a key component of Expo 2030 Riyadh’s enduring legacy.
More than 145 countries have confirmed their participation in Expo 2030 Riyadh, with formal Participation Contracts beginning to follow as preparations advance. This includes the recent signing of France’s Participation Contract last month in Paris, on the sidelines of the visit of His Royal Highness Prince Mohammed bin Salman bin Abdulaziz Al Saud, Crown Prince and Prime Minister, to France.
This momentum in international participation builds on the recent signing of the See Agreement between the Kingdom of Saudi Arabia and the Bureau International des Expositions (BIE), which establishes the legal and administrative framework governing the participation of countries and international organisations. It also reflects the tangible progress across the broader preparations for Expo 2030 Riyadh. Development of the Expo site, infrastructure and construction works continues at pace, alongside the advancement of operational planning and the development of distinctive experiences that will help shape the event and enrich the visitor journey.
Expo 2030 Riyadh will take place from 1 October 2030 to 31 March 2031 under the theme “Foresight for Tomorrow.” The six-month event is expected to bring together more than 200 Official Participants and welcome 42 million visits. Through national pavilions, cultural programming, innovation and immersive experiences, Expo 2030 Riyadh will provide a global platform for international collaboration and exchange.
About Expo 2030 Riyadh
Running from 1 October 2030 to 31 March 2031, Expo 2030 Riyadh will be among the most ambitious World Expos ever conceived with a 6 million square meter site that will bring together more than 200 Official Participants and is expected to welcome 42 million visits across 5 distinct districts.
Held under the theme “Foresight for Tomorrow,” and hosted in Riyadh - a city of action and ambition - Expo 2030 Riyadh will provide a platform for participants to exchange ideas, shape solutions, and build partnerships that drive real impact, address global challenges, and unlock new opportunities. The World Expo will feature immersive cultural zones, daily activations, and AI-powered interactions, blending traditional Saudi hospitality with cutting-edge technology. Following the six-month event, the site will evolve into a global village, continuing to attract visitors and contribute to Riyadh’s dynamic urban landscape.
For more information, please visit: https://www.expo2030riyadh.sa/en/
View source version on businesswire.com: https://www.businesswire.com/news/home/20260903144412/en/

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press release
Potential first-in-class GPC3 x 4-1BB bispecific achieves a 36% confirmed response rate at Phase 3 dose and favorable safety profile in heavily pretreated liver cancerBrain-penetrant PRMT5 inhibitor shows promising antitumor and CNS activity in the largest publicly shared MTAP-deficient datasetFirst clinical data of CEA-targeting ADC demonstrates encouraging and sustained responses in CEAhigh NSCLC BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to dise
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release
- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release
New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release
Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom